With this approval, DoKaSch will be able to co-operate with US airlines and it will also pave the way for Canadian airlines, enabling the company to expand its operations within these networks to and from the US, Canada and within the Americas.
Douglas Wettergren, CEO of DoKaSch Americas, said: “The FAA approval for our Opticooler is an important step in expanding our international network and strengthening our position. Since the USA is an important export market for pharmaceuticals, we are focusing time and energy with key clients. We have come a long way in 2019 and now that we are able to co-operate with USA flag carriers and some wet lease freighter operators, our customers can truly benefit. FAA approval is the recognition a lot of our American customers have been waiting for.”
A fleet of Opticoolers is already available at more than 25 international US airports, serving the US pharmaceutical industry, which represents a huge and growing market. High value biotech products in particular represent a growing market and require precise temperature ranges to be transported safely.
The Opticooler addresses these needs, keeping cargo accurate within the 2-8°C or 15-25°C range. It is available in two sizes, an Opticooler RAP, providing space for four CP1 pallets, and an RKN size for one pallet.